4.7 Article

DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice

期刊

JOURNAL OF EXPERIMENTAL MEDICINE
卷 208, 期 11, 页码 2305-2320

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20110345

关键词

-

资金

  1. National Institutes of Health [U54 AI054523]
  2. Wellcome Trust
  3. National Health and Medical Research Council (NHMRC)
  4. Australian Research Council
  5. Medical Research Council [G0901117] Funding Source: researchfish
  6. MRC [G0901117] Funding Source: UKRI

向作者/读者索取更多资源

In humans, DOCK8 immunodeficiency syndrome is characterized by severe cutaneous viral infections. Thus, CD8 T cell function may be compromised in the absence of DOCK8. In this study, by analyzing mutant mice and humans, we demonstrate a critical, intrinsic role for DOCK8 in peripheral CD8 T cell survival and function. DOCK8 mutation selectively diminished the abundance of circulating naive CD8 T cells in both species, and in DOCK8-deficient humans, most CD8 T cells displayed an exhausted CD45RA(+) CCR7(-). phenotype. Analyses in mice revealed the CD8 T cell abnormalities to be cell autonomous and primarily postthymic. DOCK8 mutant naive CD8 T cells had a shorter lifespan and, upon encounter with antigen on dendritic cells, exhibited poor LFA-1 synaptic polarization and a delay in the first cell division. Although DOCK8 mutant T cells underwent near-normal primary clonal expansion after primary infection with recombinant influenza virus in vivo, they showed greatly reduced memory cell persistence and recall. These findings highlight a key role for DOCK8 in the survival and function of human and mouse CD8 T cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Medicine, General & Internal

Response to: COVID-19 vaccine equity: the need of the hour

P. Maclean, A. J. Mentzer, T. Lambe, J. C. Knight

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2023)

Meeting Abstract Immunology

Why are you hitting yourself? Whole-exome sequencing diagnosis of monogenic autoimmunity

Lina Castano-Jaramillo, Francisco Rivas Larrauri, Selma Cecilia Scheffler-Mendoza, Alonso Gutierrez Hernandez, Sandra Rajme, Ana Luisa Rodriguez-Lozano, Marco Antonio Yamazaki-Nakashimada, Sara Elva Espinosa-Padilla, Saul Lugo Reyes

CLINICAL IMMUNOLOGY (2023)

Review Allergy

Inherited and acquired errors of type I interferon immunity govern susceptibility to COVID-19 and multisystem inflammatory syndrome in children

Giorgia Bucciol, Isabelle Meyts

Summary: Since the start of the COVID-19 pandemic, global sequencing efforts have made significant advancements in the field of inborn errors of immunity. Research has revealed that both known and novel inborn errors affecting type I interferon immunity play a critical role in severe COVID-19 cases, occurring in up to 5% of patients. Furthermore, autoantibodies against type I interferons have been found in around 20% of critically ill COVID-19 patients over 80 years old and 20% of fatal cases, with a higher prevalence in older males. Additionally, inborn errors impairing the regulation of type I interferon responses and RNA degradation have been identified as causes of multisystem inflammatory syndrome in children, which is a life-threatening condition that occurs following mild initial SARS-CoV-2 infection in children and young adults. Understanding these immunologic mechanisms can assist in the development of treatments for severe COVID-19, multisystem inflammatory syndrome in children, long COVID, and neuro-COVID.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Article Immunology

Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia

Ana Garcia-Garcia, Rebeca Perez de Diego, Carlos Flores, Darawan Rinchai, Jordi Sole-Violan, Angela Deya-Martinez, Blanca Garcia-Solis, Jose M. Lorenzo-Salazar, Elisa Hernandez-Brito, Anna-Lisa Lanz, Leen Moens, Giorgia Bucciol, Mohamed Almuqamam, Joseph Domachowske, Elena Colino, Juan Luis Santos-Perez, Francisco Marco, Claudio Pignata, Aziz Bousfiha, Stuart Turvey, Stefanie Bauer, Filomeen Haerynck, Javier Gonzalo Ocejo-Vinyals, Francisco Lendinez, Seraina Prader, Nora Naumann-Bartsch, Jana Pachlopnik Schmid, Catherine Biggs, Kyla Hildebrand, Alexandra Dreesman, Miguel Angel Cardenes, Fatima Ailal, Ibtihal Benhsaien, Giuliana Giardino, Agueda Molina-Fuentes, Claudia Fortuny, Swetha Madhavarapu, Daniel Conway, Carolina Prando, Laire Schidlowski, Maria Teresa Martinez de Saavedra Alvarez, Rafael Alfaro, Felipe Rodriguez de Castro, Isabelle Meyts, Fabian Hauck, Anne Puel, Paul Bastard, Bertrand Boisson, Emmanuelle Jouanguy, Laurent Abel, Aurelie Cobat, Qian Zhang, Jean-Laurent Casanova, Laia Alsina, Carlos Rodriguez-Gallego

Summary: X-linked recessive deficiency of TLR7 impairs SARS-CoV-2 recognition and type I IFN production, resulting in hypoxemic COVID-19 pneumonia. 22 unvaccinated patients with autosomal recessive MyD88 or IRAK-4 deficiency were infected with SARS-CoV-2, with a high risk of severe pneumonia. Impaired TLR7-dependent type I IFN production contributes to their susceptibility to SARS-CoV-2.

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Article Immunology

Human RELA dominant-negative mutations underlie type I interferonopathy with autoinflammation and autoimmunity

Kunihiko Moriya, Tomohiro Nakano, Yoshitaka Honda, Miyuki Tsumura, Masato Ogishi, Motoshi Sonoda, Masahiko Nishitani-Isa, Takashi Uchida, Mohamed Hbibi, Yoko Mizoguchi, Masataka Ishimura, Kazushi Izawa, Takaki Asano, Fumihiko Kakuta, Daiki Abukawa, Darawan Rinchai, Peng Zhang, Naotomo Kambe, Aziz Bousfiha, Takahiro Yasumi, Bertrand Boisson, Anne Puel, Jean-Laurent Casanova, Ryuta Nishikomori, Shouichi Ohga, Satoshi Okada, Yoji Sasahara, Shigeo Kure

Summary: This study reports six patients from five families with RELA mutations, leading to autoinflammatory and autoimmune manifestations. The mutations result in loss of function of RelA protein, leading to excessive IFN expression and autoimmune response. The DN RELA mutations are identified as a novel cause of chronic mucocutaneous ulcerations with autoinflammatory and autoimmune manifestations.

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Review Immunology

Inborn errors of human B cell development, differentiation, and function

Stuart G. Tangye, Tina Nguyen, Elissa K. Deenick, Vanessa L. Bryant, Cindy S. Ma

Summary: The fundamental importance of human B cells in host defense against infectious diseases has been established through the discovery of inborn errors that disrupt B cell development, differentiation, or function. These findings have provided a foundation for understanding disease mechanisms and finding ways to improve humoral immunity and treat diseases.

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Article Biochemistry & Molecular Biology

Autoantibodies Neutralizing Type III Interferons Are Uncommon in Patients with Severe Coronavirus Disease 2019 Pneumonia

Martti Vanker, Karita Sarekannu, Arnaud Fekkar, Sofie Eg Jorgensen, Liis Haljasmagi, Anne Kallaste, Kalle Kisand, Margus Lember, Part Peterson, Madhvi Menon, Tracy Hussell, Sean Knight, James Moore-Stanley, Paul Bastard, Shen-Ying Zhang, Trine Mogensen, Quentin Philippot, Qian Zhang, Anne Puel, Jean-Laurent Casanova, Kai Kisand

Summary: Autoantibodies neutralizing type I interferons are present in 15% of critical COVID-19 cases, while the impact of autoimmunity toward type III interferons remains unexplored. In a study of COVID-19 patients and SARS-CoV-2naive individuals, it was found that autoantibodies targeting interferon-alpha were more common and associated with older age, while autoreactivity to interferon-gamma did not correlate with severe disease in COVID-19 patients.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2023)

Article Pediatrics

Clinical Presentation and Outcomes of Kawasaki Disease in Children from Latin America: A Multicenter Observational Study from the REKAMLATINA Network

Hari K. Narayan, Anel Lizcano, Tracy Lam-Hine, Rolando Ulloa-Gutierrez, Emelia V. Bainto, Luis M. Garrido-Garcia, Dora Estripeaut, Olguita del Aguila, Virgen Gomez, Enrique Faugier-Fuentes, Greta Mino-Leon, Sandra Beltran, Fernanda Cofre, Enrique Chacon-Cruz, Patricia Saltigeral-Simental, Lucila Martinez-Medina, Lourdes Duenas, Kathia Luciani, Francisco J. Rodriguez-Quiroz, German Camacho Moreno, Tamara Viviani, Martha I. Alvarez-Olmos, Heloisa Helena de Sousa Marques, Eduardo Lopez-Medina, Maria C. Pirez, Adriana H. Tremoulet

Summary: This study described the clinical presentation, management, and outcomes of Kawasaki disease (KD) in Latin America and evaluated early prognostic indicators of coronary artery aneurysm (CAA). The results showed that a maximum coronary artery z-score >= 2.5 at initial presentation was the most important prognostic factor preceding CAA during follow-up.

JOURNAL OF PEDIATRICS (2023)

Article Immunology

Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005)

Anthonet L. Koen, Alane Izu, Vicky Baillie, Gaurav Kwatra, Clare L. Cutland, Lee Fairlie, Sherman D. Padayachee, Keertan Dheda, Shaun L. Barnabas, Qasim Ebrahim Bhorat, Carmen Briner, Khatija Ahmed, Sutika Bhikha, Jinal N. Bhiman, Jeanine du Plessis, Aliasgar Esmail, Elizea Horne, Shi-Hsia Hwa, Aylin Oommen-Jose, Teresa Lambe, Matt Laubscher, Mookho Malahleha, Gabriella Benade, Shakeel McKenzie, Suzette Oelofse, Faeezah Patel, Sureshnee Pillay, Sarah Rhead, Hylton Rodel, Carol Taoushanis, Houriiyah Tegally, Asha Thombrayil, Tonya L. Villafana, Sarah Gilbert, Andrew J. Pollard, Shabir A. Madhi

Summary: The final analysis of the COV005 study in South African adults showed that the efficacy of the AZD1222 vaccine varied against different SARS-CoV-2 variants. The vaccine had high efficacy against the wild type virus, but lower efficacy against the Beta and Delta variants. Safety was consistent with previous findings.

VACCINE (2023)

Letter Rheumatology

Notes on cutaneous manifestations of Kawasaki disease and multisystem inflammatory syndrome in children

Luisa Berenise Gamez-Gonzalez, Rolando Ulloa-Gutierrez, Marco Antonio Yamazaki-Nakashimada

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2023)

Article Multidisciplinary Sciences

Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history

Hailey R. Hornsby, Alexander R. Nicols, Stephanie Longet, Chang Liu, Adriana Tomic, Adrienn Angyal, Barbara K. Kronsteiner, Jessica K. Tyerman, Tom Tipton, Peijun Zhang, Marta Gallis, Piyada Supasa, Muneeswaran Selvaraj, Priyanka Abraham, Isabel Neale, Mohammad A. Ali, Natalie M. Barratt, Jeremy Nell, Lotta Gustafsson, Scarlett Strickland, Irina Grouneva, Timothy C. Rostron, Shona M. Moore, Luisa L. Hering, Susan L. Dobson, Sagida Bibi, Juthathip Mongkolsapaya, Teresa Lambe, Dan Wootton, Victoria Hall, Susan Hopkins, Tao Dong, Eleanor Barnes, Gavin Screaton, Alex Richter, Lance Turtle, Sarah L. Rowland-Jones, Miles Carroll, Christopher J. A. Duncan, Paul Klenerman, Susanna J. Dunachie, Rebecca P. Payne, Thushan de Silva

Summary: The authors characterized the immune response in vaccinated individuals infected with the Omicron variant and observed immune enhancement. They found that increases in neutralizing antibodies and spike T cells were stronger in individuals with no previous infection, while mucosal antibodies and non-spike responses increased regardless of infection history. The findings suggest that hybrid immunity induced by Omicron breakthrough infections can provide significant immune enhancement to protect against future variants.

NATURE COMMUNICATIONS (2023)

Review Medicine, Research & Experimental

Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs

Jean-Laurent Casanova, Mark S. Anderson

Summary: Since 2003, rare inborn errors of human type I IFN immunity have been discovered, each underlying severe viral illnesses. In 2006, autoantibodies neutralizing type I IFNs due to rare inborn errors of autoimmune regulator (AIRE)-driven T cell tolerance were discovered, but not initially linked to any viral disease. These two lines of clinical investigation converged in 2020, revealing that deficiencies of type I IFN immunity accounted for a significant percentage of critical COVID-19 cases in unvaccinated individuals.

JOURNAL OF CLINICAL INVESTIGATION (2023)

Article Medicine, General & Internal

Adenoviral vectored vaccination protects against Crimean- Congo Haemorrhagic Fever disease in a lethal challenge model

Jack E. Saunders, Ciaran Gilbride, Stuart Dowall, Susan Morris, Marta Ulaszewska, Alexandra J. Spencer, Emma Rayner, Victoria A. Graham, Emma Kennedy, Kelly Thomas, Roger Hewson, Sarah C. Gilbert, Sandra Belij-Rammerstorfer, Teresa Lambe

Summary: In this study, a preclinical assessment of a chimpanzee adenoviral vectored vaccine (ChAdOx2 CCHF) against Crimean-Congo Haemorrhagic Fever virus (CCHFV) was conducted. The results showed that ChAdOx2 CCHF vaccine induced both cellular and humoral immune responses in mice and provided 100% protection in a lethal CCHF challenge model. Additionally, the combination of ChAdOx2 CCHF vaccine with Modified Vaccinia Ankara vaccine (MVA CCHF) elicited the highest levels of CCHFV-specific cell-mediated and antibody responses in mice.

EBIOMEDICINE (2023)

Review Immunology

The trajectory of human B-cell function, immune deficiency, and allergy revealed by inborn errors of immunity

Stuart G. Tangye, Joseph Mackie, Karrnan Pathmanandavel, Cindy S. Ma

Summary: The essential role of B cells is to produce immunoglobulins that can recognize and neutralize pathogens. Understanding the signaling pathways in B cells is crucial for understanding immune dyscrasias and developing effective immune responses.

IMMUNOLOGICAL REVIEWS (2023)

暂无数据